InvestorsHub Logo

BlackDoggie

11/10/17 7:31 PM

#18108 RE: gestalt2 #18107

Sounds like we're largely in agreement on our suspicions. Hope we're correct!

Inoviorulez

11/10/17 7:57 PM

#18109 RE: gestalt2 #18107

Listen to the call. The CEO explains why. The FDA changed their minds. The FDA changed their minds after they saw the submitted results/data. The FDA decided that for the data to be clinically relevant Cytodyn would have to have 50 patients total for analysis. Plain and simple the FDA changed their minds along the way.